Search results

Found 5,192 pages
AUTHOR: Kevin Grogan

Results per page

10 20 50 100

Sort by

Relevance Date

7 Sep 2010:

Shire launches bid to buy Movetis

Shire has launched its 19 euros per share offer for Belgium's Movetis. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/shire_launches_bid_to_buy_movetis_982484

5 Jan 2015:

B-MS inks fibrosis pact with Calibr

Bristol-Myers Squibb has linked up with the California Institute for Biomedical Research to develop anti-fibrotic therapies. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/b-ms_inks_fibrosis_pact_with_calibr_970805

1 Feb 2011:

Bayer streamlines healthcare ops

Bayer is putting in place measures which it claims will cut down on administration and promote innovation. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/bayer_streamlines_healthcare_ops_979675

25 Jul 2013:

Recordati acquires Tunisia's Opalia

Recordati is buying a 90% stake in Opalia Pharma of Tunisia in a deal valued at 80 million dinar, or around 37 million euros. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/recordati_acquires_tunisias_opalia_1005440

10 Jan 2014:

Shire extends offer for ViroPharma again

Shire has extended its tender offer to buy ViroPharma for a second time, now expiring on midnight January 23. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/shire_extends_offer_for_viropharma_again_1001342

8 Jan 2015:

Roche signs Parkinson's pact with 23andMe

Roche’s Genentech unit has linked up with personal genetics company 23andMe to identify new therapeutic targets for Parkinson’s disease. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/roche_signs_parkinsons_pact_with_23andme_970837

8 Jan 2014:

Nestle pact with stem cell biotech CDI

Food giant Nestle has linked up with USA-based stem cell specialist Cellular Dynamics International. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/nestle_pact_with_stem_cell_biotech_cdi_1001327

27 Nov 2012:

XTL buys Teva's stake in Proteologics

XTL Biopharmaceuticals has bought a major stake in fellow Israeli drugmaker Proteologics from Teva Pharmaceutical Industries. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/xtl_buys_tevas_stake_in_proteologics_976154

27 Apr 2014:

Europe approves J&J diabetes combo Vokanamet

Regulators in Europe have given the green light to Johnson & Johnson's new diabetes therapy Vokanamet. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/europe_approves_j_and_j_diabetes_combo_vokanamet_1001869

10 Feb 2015:

Roche buys German genomics group Signature

Roche has hit the acquisition trail again to buy privately-held Signature Diagnostics of Germany. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/roche_buys_german_genomics_group_signature_971024